NDS Updates
March 13, 2023
A virtual meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on March 5, 2023 with the following interim recommendations made: Any objections…
NAPRA Updates
March 10, 2023
NAPRA is presently recruiting a Manager, Registration and Licensure. Deadline to apply: March 15, 2023.
NAPRA Updates
March 9, 2023
NAPRA is presently recruiting a Pharmacist Specialist, Registration and Licensure. Deadline to apply: March 15, 2023.
NAPRA Updates
March 1, 2023
December 31, 2022, marked the end of the Pilot Program to Prepare for Practical Training (P4T). The National Association of Pharmacy Regulatory Authorities (NAPRA) launched…
NAPRA Updates
February 15, 2023
Note: This recruitment posting is now closed. The National Association of Pharmacy Regulatory Authorities (NAPRA) is presently recruiting a Manager, Registration and Licensure. This role…
NAPRA Updates
February 14, 2023
Note: This recruitment posting is now closed. The National Association of Pharmacy Regulatory Authorities (NAPRA) is presently recruiting a Pharmacist Specialist, Registration and Licensure. This…
NAPRA Updates
February 8, 2023
2023 national statistics of pharmacists, pharmacy technicians and pharmacies in Canada.
Updates on Practice Resources
January 25, 2023
Updated charts summarizing the current scope of practice for pharmacists and pharmacy technicians in each province and territory effective November 2022.
NAPRA Updates
January 11, 2023
The Pilot Program to Prepare for Practical Training (P4T) has come to its successful completion on December 31, 2022.
NDS Updates
January 6, 2023
The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for March 5, 2023. The primary purpose of the meeting is to…
NAPRA Updates
November 24, 2022
The National Association of Pharmacy Regulatory Authorities (NAPRA) is pleased to announce the launch of its newly redesigned bilingual website. With its updated visual style,…
NDS Updates
November 15, 2022
The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on September 18, 2022 that: were finalized effective November 10, 2022. Final approval…